Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain

Protein Science

Volumn 24, Issue 1, 2015, Pages 81-92

  Joseph, Prem Raj B ^a   Rajarathnam, Krishna ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

affinity; CXCL8; human CXCR1 N domain; monomer dimer equilibrium; solution NMR

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; DIMER; INTERLEUKIN 8; MONOMER; RECEPTOR PROTEIN; PROTEIN BINDING;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; DISSOCIATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; MOLECULAR INTERACTION; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTON NUCLEAR MAGNETIC RESONANCE; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; BINDING SITES; HUMANS; INTERLEUKIN-8; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-8A;

EID: 84928967172     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2590     Document Type: Article

References (50)

1. Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A, (2009) Chemokines and chemokine receptors: an overview. Front Biosci 14: 540-551.
2. Zlotnik A, Yoshie O, (2012) The chemokine superfamily revisited. Immunity 36: 705-716.
3. Griffith JW, Sokol CL, Luster AD, (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32: 659-702.
4. Salanga CL, Handel TM, (2011) Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res 317: 590-601.
5. O'Hayre M, Salanga CL, Handel TM, Allen SJ, (2008) Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409: 635-649.
6. Fernandez EJ, Lolis E, (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42: 469-499.
7. Baggiolini M, Dewald B, Moser B, (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55: 97-179.
8. Baggiolini M, Dewald B, Moser B, (1997) Human chemokines: an update. Annu Rev Immunol 15: 675-705.
9. Stillie R, Farooq SM, Gordon JR, Stadnyk AW, (2009) The functional significance behind expressing two IL-8 receptor types on PMN. J Leukoc Biol 86: 529-543.
10. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM, (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry 29: 1689-1696.
11. Baldwin ET, Weber IT, St Charles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BF, Clore GM, Gronenborn AM, Wlodawer A, (1991) Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 88: 502-506.
12. Rajarathnam K, Clark-Lewis I, Sykes BD, (1995) 1H NMR solution structure of an active monomeric interleukin-8. Biochemistry 34: 12983-12990.
13. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I, (1994) Neutrophil activation by monomeric interleukin-8. Science 264: 90-92.
14. Rajarathnam K, Prado GN, Fernando H, Clark-Lewis I, Navarro J, (2006) Probing receptor binding activity of interleukin-8 dimer using a disulfide trap. Biochemistry 45: 7882-7888.
15. Nasser MW, Raghuwanshi SK, Grant DJ, Jala VR, Rajarathnam K, Richardson RM, (2009) Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. J Immunol 183: 3425-3432.
16. Rajagopalan L, Rajarathnam K, (2006) Structural basis of chemokine receptor function-a model for binding affinity and ligand selectivity. Biosci Rep 26: 325-339.
17. Wells TN, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung CW, Peitsch MC, Proudfoot AE, (1996) Selectivity and antagonism of chemokine receptors. J Leukoc Biol 59: 53-60.
18. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I, (1997) Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16: 6996-7007.
19. Joseph PR, Sarmiento JM, Mishra AK, Das ST, Garofalo RP, Navarro J, Rajarathnam K, (2010) Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. J Biol Chem 285: 29262-29269.
20. Rajagopalan L, Rajarathnam K, (2004) Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain. J Biol Chem 279: 30000-30008.
21. Fernando H, Chin C, Rösgen J, Rajarathnam K, (2004) Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor. J Biol Chem 279: 36175-36178.
22. Fernando H, Nagle GT, Rajarathnam K, (2007) Thermodynamic characterization of interleukin-8 monomer binding to CXCR1 receptor N-terminal domain. FEBS J 274: 241-251.
23. Ravindran A, Joseph PR, Rajarathnam K, (2009) Structural basis for differential binding of the interleukin-8 monomer and dimer to the CXCR1 N-domain: role of coupled interactions and dynamics. Biochemistry 48: 8795-8805.
24. Clubb RT, Omichinski JG, Clore GM, Gronenborn AM, (1994) Mapping the binding surface of interleukin-8 complexed with an N-terminal fragment of the type 1 human interleukin-8 receptor. FEBS Lett 338: 93-97.
25. Barter EF, Stone MJ, (2012) Synergistic interactions between chemokine receptor elements in recognition of interleukin-8 by soluble receptor mimics. Biochemistry 51: 1322-1331.
26. Park SH, Casagrande F, Cho L, Albrecht L, Opella SJ, (2011) Interactions of interleukin-8 with the human chemokine receptor CXCR1 in phospholipid bilayers by NMR spectroscopy. J Mol Biol 414: 194-203.
27. Kendrick AA, Holliday MJ, Isern NG, Zhang F, Camilloni C, Huynh C, Vendruscolo M, Armstrong G, Eisenmesser EZ, (2014) The dynamics of interleukin-8 and its interaction with human CXC receptor I peptide. Protein Sci 23: 464-480.
28. Joseph PR, Sawant KV, Isley A, Pedroza M, Garofalo RP, Richardson RM, Rajarathnam K, (2013) Dynamic conformational switching in the chemokine ligand is essential for G Protein coupled-receptor activation. Biochem J 456: 241-51.
29. Girrbach M, Meliciani I, Waterkotte B, Berthold S, Oster A, Brurein F, Strunk T, Wadhwani P, Berensmeier S, Wenzel W, Schmitz K, (2014) A fluorescence polarization assay for the experimental validation of an in silico model of the chemokine CXCL8 binding to receptor-derived peptides. Phys Chem Chem Phys 16: 8036-8043.
30. Burrows SD, Doyle ML, Murphy KP, Franklin SG, White JR, Brooks I, McNulty DE, Scott MO, Knutson JR, Porter D, Young PR, Hensley P, (1994) Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 33: 12741-12745.
31. Paolini JF, Willard D, Consler T, Luther M, Krangel MS, (1994) The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J Immunol 153: 2704-2717. (Erratum in 1996;156(8):following 3088).
32. Rajarathnam K, Kay CM, Clark-Lewis I, Sykes BD, (1997) Characterization of quaternary structure of interleukin-8 and functional implications. Methods Enzymol 287: 89-105.
33. Lowman HB, Fairbrother WJ, Slagle PH, Kabakoff R, Liu J, Shire S, Hebert CA, (1997) Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation. Protein Sci 6: 598-608.
34. Jin H, Hayes GL, Darbha NS, Meyer E, LiWang PJ, (2005) Investigation of CC and CXC chemokine quaternary state mutants. Biochem Biophys Res Commun 338: 987-999.
35. Joseph PR, Poluri KM, Gangavarapu P, Rajagopalan L, Raghuwanshi S, Richardson RM, Garofalo RP, Rajarathnam K, (2013) Proline substitution of dimer interface β-strand residues as a strategy for the design of functional monomeric proteins. Biophys J 105: 1491-1501.
36. Williamson MP, (2013) Using chemical shift perturbation to characterise ligand binding. Prog Nucl Magn Reson Spectrosc 73: 1-16.
37. Attwood MR, Borkakoti N, Bottomley GA, Conway EA, Cowan I, Fallowfield AG, Handa BK, Jones PS, Keech E, Kirtland SJ, Williams G, Wilson FX, (1996) Identification and characterisation of an inhibitor of interleukin-8: a receptor based approach. Bioorganic Med Chem Lett 6: 1869-1874.
38. Daly TJ, LaRosa GJ, Dolich S, Maione TE, Cooper S, Broxmeyer HE, (1995) High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. J Biol Chem 270: 23282-23292.
39. Williams MA, Cave CM, Quaid G, Robinson C, Daly TJ, Witt D, Lentsch AB, Solomkin JS, (2005) Interleukin 8 dimerization as a mechanism for regulation of neutrophil adherence-dependent oxidant production. Shock 23: 371-376.
40. Lusti-Narasimhan M, Power CA, Allet B, Alouani S, Bacon KB, Mermod JJ, Proudfoot AE, Wells TN, (1995) Mutation of Leu25 and Val27 introduces CC chemokine activity into interleukin-8. J Biol Chem 270: 2716-2721.
41. Horcher M, Rot A, Aschauer H, Besemer J, (1998) IL-8 derivatives with a reduced potential to form homodimers are fully active in vitro and in vivo. Cytokine 10: 1-12.
42. LaRosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, Taylor L, Gray G, Witt D, Navarro J, (1992) Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 267: 25402-25406.
43. Gayle RB, Sleath PR, Srinivason S, Birks CW, Weerawarna KS, Cerretti DP, Kozlosky CJ, Nelson N, Vanden Bos T, Beckmann MP, (1993) Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J Biol Chem 268: 7283-7289.
44. Park SH, Casagrande F, Das BB, Albrecht L, Chu M, Opella SJ, (2011) Local and global dynamics of the G protein-coupled receptor CXCR1. Biochemistry 50: 2371-2380.
45. Skelton NJ, Quan C, Reilly D, Lowman H, (1999) Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure 7: 157-168.
46. Park SH, Das BB, Casagrande F, Tian Y, Nothnagel HJ, Chu M, Kiefer H, Maier K, De Angelis AA, Marassi FM, Opella SJ, (2012) Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature 491: 779-783.
47. Szpakowska M, Fievez V, Arumugan K, van Nuland N, Schmit JC, Chevigné A, (2012) Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors. Biochem Pharmacol 84: 1366-1380.
48. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR, (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
49. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A, (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
50. Johnson BA, Blevins RA, (1994) NMR view: a computer program for the visualization and analysis of NMR data. J Biomol NMR 4: 603-614.